Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Alpine Immune Sciences (ALPN) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 22 quarters since 2016. Compare with ALPN stock chart to see long term trends.

ALPN stock compared to

ALPN Income Statement

Revenue, Net:7193000
Revenue Per Share:0.3
Research & Development Expense:14634000
Total Operating Expenses:17924000
Operating Income:-10898000
Income Taxes:131000
Net Income:-11029000
Earnings Per Share, Basic:-0.46
Shares Outstanding, Basic Avg:23914879

ALPN Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-14682000
Issuance of Long-term Debt:0
Net Cash from Financing Activities:9000
Property, Plant & Equipment Purchases:30000
Net Cash from Investing Activities:20866000
Net Change in Cash & Equivalents:6184000

ALPN Balance Sheet

Cash and Cash Equivalents:19067000
Accounts Receivable, Net:45343000
Total Current Assets:139736000
Property, Plant & Equipment, Net:1527000
Total Assets:159818000
Accounts Payable:1393000
Current Portion of Long-Term Debt:4567000
Total Short-Term Liabilities:60246000
Long Term Debt, Non-Current Portion:5707000
Total Liabilities:115987000

Insider Trading

Change
Value
Transaction
SEC Form 4
CONWAY ROBERT E   Director
 
 
Buy
Peetz Christopher   Director
 
 
Buy
CONWAY ROBERT E   Director
 
 
Buy
Decheng Capital China Life Sciences USD Fund III, L.P.   10% Owner
1,542,553 sh at $9
$14,499,998
Buy
Thompson Peter A.   Director and 10% Owner
 
 
Buy
ORBIMED ADVISORS LLC   Director and 10% Owner
 
 
Buy
Cui Xiangmin   Director and 10% Owner
 
 
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Orbimed Advisors LLC
3,070,955 sh
 
$27,639
Frazier Management LLC
2,571,450 sh
 
$23,143
Avidity Partners Management Lp
1,495,000 sh
-16,000 sh
-1%
$13,455
-$2,562
Omega Fund Management, LLC
1,284,900 sh
 
$11,564
Artal Group S.A.
593,030 sh
 
$5,337
Vanguard Group Inc
575,217 sh
-126 sh
0%
$5,176
-$923
Blackrock Inc.
544,155 sh
517,399 sh
1934%
$4,898
$4,614
Ecor1 Capital, LLC
522,635 sh
-218,655 sh
-29%
$4,704
-$3,154
Renaissance Technologies LLC
398,994 sh
2,100 sh
1%
$3,591
-$616
Ikarian Capital, LLC
300,454 sh
-4,285 sh
-1%
$2,704
-$526
Samsara Biocapital, LLC
275,169 sh
-124,021 sh
-31%
$2,477
-$1,754
Geode Capital Management, LLC
191,538 sh
99,396 sh
108%
$1,723
$747
State Street Corp
173,119 sh
173,119 sh
NEW
$1,558
$1,558
Bridgeway Capital Management Inc
153,611 sh
153,611 sh
NEW
$1,382
$1,382
Tiger Management L.L.C.
137,728 sh
 
$1,240
Deutsche Bank Ag\
134,057 sh
-110,275 sh
-45%
$1,207
-$1,383
Northern Trust Corp
113,579 sh
93,666 sh
470%
$1,022
$811
Dafna Capital Management LLC
113,302 sh
 
$1,020
Two Sigma Advisers, Lp
69,175 sh
-56,800 sh
-45%
$623
-$712
Acadian Asset Management LLC
67,156 sh
18,615 sh
38%
$604
$89

Data imported from Alpine Immune Sciences Inc SEC filings. Check original filings before making any investment decision.